I think what we may be confusing here is, I might do development batches – process development – and never intend to put those into a clinical trial. Then, after I’ve developed the process somewhat, I will manufacture batches to put into a clinical trial. So the concern is that, is ICH Q7A saying here that there will be some GMPs applied to that development work? Clearly, I think the answer’s no.